Short report: Severe myalgia of the lower extremities as the first clinical feature of meningococcal purpura fulminans

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 4, 2007, Pages 723-726

  De Souza, Alexandre Leite ^a   Sztajnbok, Jaques ^b   Salgado, Maristela Marques ^b   Romano, Carla C ^b   Alkmin, Maria Das Graças Adelino ^b   Duarte, Alberto J S ^b   Seguro, Antonio Carlos ^b  

^a NONE   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; VITAMIN K GROUP;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FULMINATING PURPURA; HUMAN; LABORATORY TEST; LEG; MALE; MENINGOCOCCOSIS; MYALGIA; NEISSERIA MENINGITIDIS; ANAPHYLACTOID PURPURA; BLOOD; CEREBROSPINAL FLUID; EPIDEMIC MENINGITIS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION;

NEISSERIA MENINGITIDIS;

ADULT; HUMANS; MALE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; PURPURA, SCHOENLEIN-HENOCH;

EID: 38449097311     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.723     Document Type: Article

References (21)

1. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M, 2006. Clinical recognition of meningococcal disease in children and adolescents. Lancet 367: 397-403.
2. Inkelis SH, O'Leary D, Wang VJ, Malley R, Nicholson MK, Kuppermann N, 2002. Extremity pain and refusal to walk in children with invasive meningococcal disease. Pediatrics 110: e3.
3. Carrol ED, Thomson AP, Mobbs KJ, Fraser WD, Sills JA, Hart CA, 2002. Myositis in children with meningococcal disease: a role for tumour necrosis factor-alpha and interleukin-8? J Infect 44: 17-21.
4. Taha M, 2000. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 38: 855-857.
5. Zenz W, Zoehrer B, Levin M, Fanconi S, Hatzis TD, Knight G, Mullner M, Faust SN, International Paediatric Meningococcal Thrombolysis Study Group, 2004. Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study. Crit Care Med 32: 1777-1780.
6. Dixon JE, Fearneyhough PK, Callen JP, 2006. Thwarting a killer. Am J Med 119: 310-311.
7. van Deuren M, van Dijke BJ, Koopman RJ, Horrevorts AM, Meis JF, Santman FW, van der Meer JW, 1993. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306: 1229-1232.
8. Apicella MA, 2005. Neisseria meningitidis. Mandell GL, Douglas RG, and Bennett JE, eds. Principles and Practices of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2498-2513.
9. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M, 1999. 4G/5G promoter polymorphism in the plasminogen-activator- inhibitor-1 gene and outcome of meningococcal disease. Lancet 354: 556-560.
10. Warner PM, Kagan RJ, Yakuboff KP, Kemalyan N, Palmieri TL, Greenhalgh DG, Sheridan RL, Mozingo DW, Heimbach DM, Gibran NS, Engrav L, Saffle JR, Edelman LS, Warden GD, 2003. Current management of purpura fulminans: a multicenter study. J Burn Care Rehabil 24: 119-126.
11. Emonts M, Hazelzet JA, de Groot R, Hermans PW, 2003. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3: 565-577.
12. Bjerre A, Ovstebo R, Kierulf P, Halvorsen S, Brandtzaeg P, 2000. Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts. Clin Infect Dis 30: 643-647.
13. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS, 2001. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345: 408-416.
14. Van Amersfoort ES, Van Berkel TJ, Kuiper J, 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16: 379-414.
15. Constantin D, Cordenier A, Robinson K, Ala'Aldeen DA, Murphy S, 2004. Neisseria meningitidis-induced death of cerebrovascular endothelium: mechanisms triggering transcriptional activation of inducible nitric oxide synthase. J Neurochem 89: 1166-1174.
16. Sotto MN, Langer B, Hoshino-Shimizu S, de Brito T, 1976. Pathogenesis of cutaneous lesions in acute meningococcemia in humans: light, immunofluorescent, and electron microscopic studies of skin biopsy specimens. J Infect Dis 133: 506-514.
17. Hoyne AL, Brown RH, 1948. 727 meningococcic cases: an analysis. Ann Intern Med 28: 248-259.
18. van Deuren M, Brandtzaeg P, van der Meer JW, 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13: 144-166.
19. de Souza AL, Sztajnbok J, Marques Salgado M, Romano CC, Alkmin MG, Duarte AJ, Seguro AC, 2006. Compartmentalization of interleukin-6 response in a patient with septic meningococcal peritonitis. Clin Vaccine Immunol 13: 1287-1290.
20. Guarner J, Greer PW, Whitnev A, Shieh WJ, Fischer M, White EH, Carlone GM, Stephens DS, Popovic T, Zaki SR, 2004. Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol 122: 754-764.
21. Arend SM, Lavrijsen AP, Kuijken I, van der Pias RN, Kuijper EJ, 2006. Prospective controlled study of the diagnostic value of skin biopsy in patients with presumed meningococcal disease. Eur J Clin Microbiol Infect Dis 25: 643-649.